Download Philadelphia presentation

yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Improved Monitoring of Tumour Growth with a
Novel Serum Proliferation Biomarker
We hope that you will be able to attend AroCell’s presentation at the 13th Annual Biomarkers &
Immuno-Oncology World Congress 2017
Stream: Translational Biomarkers in Drug Discovery
Time and Place: Wednesday: May 3, 09.20-09.35, Salon B
Presenter: Martin Shaw, Business Development Manager, AroCell.
There are many biomarkers of tumour mass, but more important is the rate of tumour growth.’
The AroCell TK 210 ELISA offers the potential to study this from a standard blood sample
Take Aways:
Cellular proliferation biomarkers are important for cancer monitoring and prognoses
Thymidine Kinase 1 (TK1) is an important proliferation biomarker but traditional serum TK1
enzyme activity assays under-estimate serum TK1 in subjects with solid tumors
The AroCell TK 210 ELISA for TK1 is specific for a unique TK1 amino acid sequence and
enables improved discrimination between subjects with different disease stages
Combining AroCell TK 210 ELISA results with traditional tumor biomarkers leads to increased
diagnostic accuracy
We look forward to seeing you.
If you cannot attend, contact Martin Shaw at [email protected] and we will be happy to
send you a copy